Prelude Capital Management, LLC Veracyte, Inc. Transaction History

Prelude Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $238,452 - $409,872	-7,239 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $49,050 - $89,762	1,103 Added 17.98%	7,239 $389,000
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $199,358 - $379,695	6,136 New	6,136 $300,000
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $1.67 Million - $2.42 Million	-80,549 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $80,227 - $103,955	-3,361 Reduced 4.01%	80,549 $1.93 Million
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $2.54 Million - $3.28 Million	-114,865 Reduced 57.79%	83,910 $2.39 Million
Q1 2019 May 15, 2019	SELL	$12.0 - $25.76 $537,588 - $1.15 Million	-44,799 Reduced 18.39%	198,775 $4.97 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $862,378 - $1.4 Million	94,249 Added 63.12%	243,574 $3.06 Million
Q3 2018 Nov 14, 2018	SELL	$9.55 - $12.64 $300,490 - $397,717	-31,465 Reduced 17.4%	149,325 $1.43 Million
Q2 2018 Aug 14, 2018	BUY	$5.39 - $9.66 $275,617 - $493,964	51,135 Added 39.44%	180,790 $1.69 Million
Q1 2018 May 15, 2018	BUY	$5.44 - $6.97 $503,412 - $644,996	92,539 Added 249.32%	129,655 $721,000
Q4 2017 Feb 14, 2018	BUY	$6.05 - $9.37 $92,661 - $143,510	15,316 Added 70.26%	37,116 $242,000
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $170,258 - $191,186	21,800	21,800 $191,000

254

82.1M

42.3K

18.2K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.35B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.